Newsletters - OCT 2002

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Dr. N. Kalyanam., President R & D along with his research group at Sabinsa’s Princeton R & D lab, developed a simplified cost effective and affordable manufacturing process for eflornithine, a drug used to fight African sleeping sickness.

Sabinsa Corporation is working in collaboration with the WHO on this project, contributing to the organization’s efforts to combat the parasitic disease that has resurged in epidemic proportions in certain parts of Africa.

A patent application for this process was recently submitted to the United States Patent and Trademark Office.

    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos Certificate Logos Certificate Logos

CONTACT US